NCT05679102View on ClinicalTrials.gov

Atorvastatin as an Antihypertensive Agent

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions
Atorvastatin Antihypertensive Effect
Interventions
DRUG

Amlodipine 5 MG Oral Tablet

one group will be given only Amlodipine 5MG once daily

DRUG

Amlodipine 5 MG / Atorvastatin 10 MG Oral Tablet

one group will be given Amlodipine 5mg plus Atorvastatin 10MG once daily

Trial Locations (1)

15526

Shaqra University, Shaqra

All Listed Sponsors
collaborator

Ayub Teaching Hospital

OTHER

collaborator

Khyber Medical University Peshawar

OTHER

lead

Himayat Ullah

OTHER